HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

EP2302

an antioxidant in hyperlipidaemic rabbits

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Biphenyl Compounds: 7
        EP2302: 3
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Oxazines: 9
    - Morpholines: 6
      - EP2302: 3

Experts

1.	Charalambous, Avgui: 2 articles (06/2008 - 03/2006)
2.	Kaklamanis, Loukas: 2 articles (06/2008 - 03/2006)
3.	Kourounakis, Angeliki P: 2 articles (06/2008 - 03/2006)
4.	Kourounakis, Panos N: 2 articles (06/2008 - 03/2006)
5.	Manolopoulos, Vangelis G: 2 articles (06/2008 - 03/2006)
6.	Papalois, Apostolos: 2 articles (06/2008 - 03/2006)
7.	Rekka, Eleni A: 2 articles (06/2008 - 03/2006)
8.	Tavridou, Anna: 2 articles (06/2008 - 03/2006)
9.	Manolopoulos, V G: 1 article (01/2009)
10.	Tavridou, A: 1 article (01/2009)

Related Diseases

1.

Atherosclerosis

06/01/2008 - "We have shown that EP2302 inhibits atherosclerosis in the cholesterol-fed rabbit and therefore may serve as a candidate drug to be tested in humans for atherosclerosis-related disorders."
06/01/2008 - "We hypothesized that EP2302 can reduce atherosclerosis in the cholesterol-fed rabbit atherosclerosis model. "
01/01/2009 - "EP2306 and EP2302 show a similar inhibitory effect in the progression of atherosclerosis in the cholesterol-fed rabbit. "
03/27/2006 - "These results suggest that EP2306 and EP2302 might prove to be useful for lipid-lowering and treatment of atherosclerosis in vivo."

Related Drugs and Biologics

1.	Cholesterol
2.	EP2306
3.	Lipids